LeonaBio, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | – | – | -76.1% | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | +5.7% | +250.3% | +222.1% | +43.6% | +52.6% | -24.6% | -75.2% | |
| – | +16.6% | +305.1% | +216.4% | +53.3% | +2.3% | -21.7% | -36.1% | |
| – | -6.3% | +283.3% | +253.1% | +63.7% | +20.6% | -19.6% | -66.1% | |
| – | – | – | – | – | – | – | – | |
| – | +3,744.4% | +6.1% | -99.2% | +810,433.3% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.